174 related articles for article (PubMed ID: 25756670)
1. Molecular factors influencing the affinity of flavonoid compounds on P-glycoprotein efflux transporter.
Vázquez RN; Camargo AB; Marchevsky EJ; Luco JM
Curr Comput Aided Drug Des; 2014; 10(3):250-8. PubMed ID: 25756670
[TBL] [Abstract][Full Text] [Related]
2. A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein.
Boccard J; Bajot F; Di Pietro A; Rudaz S; Boumendjel A; Nicolle E; Carrupt PA
Eur J Pharm Sci; 2009 Feb; 36(2-3):254-64. PubMed ID: 18955135
[TBL] [Abstract][Full Text] [Related]
3. Mini review on molecular modeling of P-glycoprotein (Pgp).
Ha SN; Hochman J; Sheridan RP
Curr Top Med Chem; 2007; 7(15):1525-9. PubMed ID: 17897039
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
5. C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance.
Comte G; Daskiewicz JB; Bayet C; Conseil G; Viornery-Vanier A; Dumontet C; Di Pietro A; Barron D
J Med Chem; 2001 Mar; 44(5):763-8. PubMed ID: 11262086
[TBL] [Abstract][Full Text] [Related]
6. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
7. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
Bansal T; Jaggi M; Khar RK; Talegaonkar S
J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
9. Herbal modulation of P-glycoprotein.
Zhou S; Lim LY; Chowbay B
Drug Metab Rev; 2004 Feb; 36(1):57-104. PubMed ID: 15072439
[TBL] [Abstract][Full Text] [Related]
10. Structure characteristics for intestinal uptake of flavonoids in Caco-2 cells.
Fang Y; Liang F; Liu K; Qaiser S; Pan S; Xu X
Food Res Int; 2018 Mar; 105():353-360. PubMed ID: 29433224
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3',4'-pentamethoxyflavone (Sinensetin).
Choi CH; Sun KH; An CS; Yoo JC; Hahm KS; Lee IH; Sohng JK; Kim YC
Biochem Biophys Res Commun; 2002 Jul; 295(4):832-40. PubMed ID: 12127970
[TBL] [Abstract][Full Text] [Related]
12. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
13. B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.
Boumendjel A; Bois F; Beney C; Mariotte AM; Conseil G; Di Pietro A
Bioorg Med Chem Lett; 2001 Jan; 11(1):75-7. PubMed ID: 11140738
[TBL] [Abstract][Full Text] [Related]
14. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
15. Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: structure-activity relationships for flavonoid binding.
de Wet H; McIntosh DB; Conseil G; Baubichon-Cortay H; Krell T; Jault JM; Daskiewicz JB; Barron D; Di Pietro A
Biochemistry; 2001 Aug; 40(34):10382-91. PubMed ID: 11513617
[TBL] [Abstract][Full Text] [Related]
16. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Structure⁻Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells.
Xia M; Fang Y; Cao W; Liang F; Pan S; Xu X
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035631
[TBL] [Abstract][Full Text] [Related]
18. A genetic algorithm- back propagation artificial neural network model to quantify the affinity of flavonoids toward P-glycoprotein.
Shen J; Cui Y; Gu J; Li Y; Li L
Comb Chem High Throughput Screen; 2014 Feb; 17(2):162-72. PubMed ID: 24206113
[TBL] [Abstract][Full Text] [Related]
19. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
[TBL] [Abstract][Full Text] [Related]
20. A quantitative structure-activity relationship for the modulation effects of flavonoids on p-glycoprotein-mediated transport.
Sheu MT; Liou YB; Kao YH; Lin YK; Ho HO
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1187-94. PubMed ID: 20823598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
